DIVISLABNSEDivi's Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Mon, 6 Apr · 15:20 IST

Divi's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

DIVISLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.3%1-day move
₹5848.50
prior close
₹5817.50
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.3+0.7+1.8+4.6+3.9+7.7+10.4+14.2+11.3+17.6
Up moveDown movePending
AI summary

Divi's Laboratories submitted a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for Q4 FY26 (January–March 2026). The certificate, issued by KFin Technologies Limited (the company's Registrar & Share Transfer Agent), confirms that all securities received for dematerialization during the quarter were properly processed and confirmed to depositories (NSDL and CDSL). It also confirms that physical share certificates were mutilated and cancelled, and depository names were substituted as registered owners in the register of members within the required 15-day period. This is a standard regulatory filing confirming proper handling of share dematerialization requests.

Likely market impact

No direct impact on stock price or operations. This is a routine mandatory compliance filing confirming proper processing of share dematerialization during the quarter.